These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6398336)

  • 21. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
    Williams GH; Dluhy RG; Moore TJ
    Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
    Coruzzi P
    J Clin Endocrinol Metab; 1994 Feb; 78(2):455-8. PubMed ID: 8106635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of low-renin hypertension: aldosterone response to sodium restriction and upright posture, angiotensin II, ACTH and potassium in patients with hypertension.
    Saito I; Saruta T; Nakamura R; Misumi J; Kondo K; Matsuki S
    Jpn Circ J; 1976 Aug; 40(8):911-9. PubMed ID: 184308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous dopaminergic activity in Child-Pugh A cirrhosis: potential role in renal sodium handling and in the maintenance of clinical compensation.
    Sansoè G; Ferrari A; Baraldi E; Grisolia C; De Santis MC; Villa E; Manenti F
    Eur J Clin Invest; 1998 Feb; 28(2):131-7. PubMed ID: 9541127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone suppression with dopamine infusion in low-renin hypertension.
    Holland OB; Thomas C; Brown H; Schindewolf D; Hillier Y; Gomez-Sanchez C
    J Clin Invest; 1983 Sep; 72(3):754-66. PubMed ID: 6309909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism].
    Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bromocriptine on renin, aldosterone, and prolactin responses to posture and metoclopramide in idiopathic edema: possible therapeutic approach.
    Sowers J; Catania R; Paris J; Tuck M
    J Clin Endocrinol Metab; 1982 Mar; 54(3):510-6. PubMed ID: 7035482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
    Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of high sodium diet on dopaminergic mechanism in normal and hypertensive subjects].
    Takahashi M; Miura Y; Sano N; Ohzeki T; Sugawara T; Noshiro T; Meguro Y; Watanabe H; Shimizu K; Hanew K
    Nihon Naibunpi Gakkai Zasshi; 1988 Nov; 64(11):1157-68. PubMed ID: 3065095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism.
    Krishna GG; Chusid P; Hoeldtke RD
    Nephron; 1987; 47(3):184-9. PubMed ID: 3683686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension.
    Sala C; Morganti A; Ferraris P; Ardeleani G; Venegoni P; Quorso P; Ambrosi B; Zanchetti A
    J Hypertens Suppl; 1988 Dec; 6(4):S336-8. PubMed ID: 2977175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of metoclopramide on aldosterone and regulatory factors in man.
    Gilchrist NL; Espiner EA; Nicholls MG; Donald RA
    Clin Endocrinol (Oxf); 1984 Jul; 21(1):1-7. PubMed ID: 6086181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
    Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine blockade abolishes the exaggerated natriuresis of essential hypertension.
    Coruzzi P; Musiari L; Biggi A; Ravanetti C; Novarini A
    J Hypertens; 1987 Oct; 5(5):587-91. PubMed ID: 3323313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absent aldosterone response to metoclopramide in patients with high spinal cord transection: evidence that metoclopramide stimulates aldosterone secretion through central pathways.
    Beck FW; Sowers JR; Sicca D; Welch BG
    Life Sci; 1985 Jun; 36(25):2435-44. PubMed ID: 2989637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia.
    Serri O
    Horm Res; 1987; 27(1):36-41. PubMed ID: 3623428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium and potassium status, plasma renin and aldosterone profiles in normotensive and hypertensive Johannesburg blacks.
    Cohen SL; Jhetam D; Da Silva J; Milne FJ; van der Walt A
    S Afr Med J; 1982 Dec; 62(25):941-4. PubMed ID: 6755766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of the renin-aldosterone system in mild essential hypertension.
    Khokhar AM; Slater JD; Jowett TP; Payne NN
    Clin Sci Mol Med; 1976 Apr; 50(4):269-76. PubMed ID: 1261208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.